期刊
INORGANIC CHEMISTRY
卷 -, 期 -, 页码 -出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.inorgchem.2c02907
关键词
-
资金
- Brown University
- National Science Foundation [CHE-1900248]
- Stony Brook University
Radioisotopes of Cu, including 64Cu and 67Cu, are promising for imaging and radiotherapeutic applications. This study presents the synthesis of a cyclen-based spirocyclic chelate and investigates its stability under physiological conditions and its comparison with other radiopharmaceuticals. The results suggest that N-protonated species are not inherently unstable and N,N-alkylation shows potential as a tool for the rational design of future radiopharmaceuticals.
Radioisotopes of Cu, such as 64Cu and 67Cu, are alluring targets for imaging (e.g., positron emission tomography, PET) and radiotherapeutic applications. Cyclen-based macrocyclic polyaminocarbox-ylates are one of the most frequently examined bifunctional chelators in vitro and in vivo, including the FDA-approved 64Cu radiopharmaceutical, Cu(DOTATATE) (Detectnet); however, connections between the structure of plausible reactive intermediates and their stability under physiologically relevant conditions remain to be established. In this study, we share the synthesis of a cyclen-based, N,N-alkylated spirocyclic chelate, HDO3AC4H8, which serves as a model for N-protonation. Our combined experimental (in vitro and in vivo) and computational studies unravel complex pH-dependent speciation and enable side-by-side comparison of N- and O-protonated species of relevant 64Cu radiopharmaceuticals. Our studies suggest that N-protonated species are not inherently unstable species under physiological conditions and demonstrate the potential of N,N-alkylation as a tool for the rational design of future radiopharmaceuticals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据